35216554|t|A young man with secondary adrenal insufficiency due to empty sella syndrome.
35216554|a|BACKGROUND: Empty sella syndrome is characterized by a constellation of symptoms that encompass various systems, and includes endocrine, neurologic, ophthalmologic, and psychiatric presentations. We here report a case of a young man presenting with severe hyponatremia due to empty sella syndrome and focus on changes in electrolytes during corticosteroid supplementation. CASE REPORT: A 36-year-old man presented with general weakness, poor appetite, and dizziness for 4 days. Physical assessment revealed lower limbs nonpitting oedema. Pertinent laboratory data showed severe hyponatremia (sodium 108 mmol/L). Endocrine work-up revealed low cortisol levels at 1.17 microg/dL (reference: 4.82-19.5 microg/dL) and inappropriately normal adrenocorticotropic hormone levels at 12.4 pg/mL (reference: 0.1-46.0 pg/mL), indicating secondary adrenal insufficiency. Brain magnetic resonance imaging confirmed the diagnosis of empty sella syndrome. He developed delirium and agitation one day after cortisol supplementation with a sodium correction rate of 10 mmol/L/day, while hypokalaemia (potassium 3.4 mmol/L) also developed. The symptoms improved after lowering the serum sodium level. This patient was eventually discharged after 12 days of hospitalization when the serum sodium and potassium levels were 139 mmol/L and 3.5 mmol/L, respectively. CONCLUSION: Herein, we address the importance of timely diagnosis of empty sella syndrome in patients with hyponatremia and highlight the close monitoring of the changes in electrolytes during corticosteroid replacement.
35216554	8	11	man	Species	
35216554	27	48	adrenal insufficiency	Disease	MESH:D000309
35216554	56	76	empty sella syndrome	Disease	MESH:D004652
35216554	90	110	Empty sella syndrome	Disease	MESH:D004652
35216554	247	258	psychiatric	Disease	MESH:D001523
35216554	307	310	man	Species	
35216554	334	346	hyponatremia	Disease	MESH:D007010
35216554	354	374	empty sella syndrome	Disease	MESH:D004652
35216554	478	481	man	Species	
35216554	505	513	weakness	Disease	MESH:D018908
35216554	515	528	poor appetite	Disease	MESH:D001068
35216554	534	543	dizziness	Disease	MESH:D004244
35216554	608	614	oedema	Disease	MESH:C536897
35216554	656	668	hyponatremia	Disease	MESH:D007010
35216554	670	676	sodium	Chemical	MESH:D012964
35216554	721	729	cortisol	Chemical	MESH:D006854
35216554	815	842	adrenocorticotropic hormone	Gene	5443
35216554	914	935	adrenal insufficiency	Disease	MESH:D000309
35216554	997	1017	empty sella syndrome	Disease	MESH:D004652
35216554	1032	1040	delirium	Disease	MESH:D003693
35216554	1045	1054	agitation	Disease	MESH:D011595
35216554	1069	1077	cortisol	Chemical	MESH:D006854
35216554	1101	1107	sodium	Chemical	MESH:D012964
35216554	1148	1160	hypokalaemia	Disease	
35216554	1162	1171	potassium	Chemical	MESH:D011188
35216554	1247	1253	sodium	Chemical	MESH:D012964
35216554	1266	1273	patient	Species	9606
35216554	1348	1354	sodium	Chemical	MESH:D012964
35216554	1359	1368	potassium	Chemical	MESH:D011188
35216554	1491	1511	empty sella syndrome	Disease	MESH:D004652
35216554	1515	1523	patients	Species	9606
35216554	1529	1541	hyponatremia	Disease	MESH:D007010
35216554	Negative_Correlation	MESH:D006854	MESH:D012964
35216554	Positive_Correlation	MESH:D012964	MESH:D003693
35216554	Negative_Correlation	MESH:D006854	MESH:D000309
35216554	Positive_Correlation	MESH:D012964	MESH:D011595
35216554	Positive_Correlation	MESH:D006854	MESH:D003693
35216554	Positive_Correlation	MESH:D006854	MESH:D011595

